View printer-friendly version

Download PDF

Emergent BioSolutions to Present at ThinkEquity’s 9th Annual Growth Conference

ROCKVILLE, Md.–(BUSINESS WIRE)–Aug. 28, 2012– Emergent BioSolutions Inc. (NYSE: EBS) announced today that the company will be webcasting its presentation at the ThinkEquity 9^th Annual Growth Conference in New York on Wednesday, September 12, 2012 at 11:15 AM Eastern. During the presentation, a member of the company’s management team will provide a corporate overview, which may include a discussion of the company’s recent business developments.

A webcast of this presentation will be available both live and by replay, accessible from the Emergent website www.emergentbiosolutions.com under “Investors”.

About Emergent BioSolutions Inc.

Emergent BioSolutions protects and enhances life by developing and manufacturing vaccines and therapeutics that are supplied to healthcare providers and purchasers for use in preventing and treating disease. Emergent’s marketed and investigational products target infectious diseases, oncology and autoimmune disorders. Additional information about the company may be found at www.emergentbiosolutions.com. Follow us on Twitter: @emergentbiosolu.

Source: Emergent BioSolutions Inc.